Larazotide
AT-1001 / Larazotide acetate
- Peptide length
- 8 amino acids
Octapeptide
Open the sources to check how the studies were done and what they can support.
A peptide investigated for persistent celiac-disease symptoms despite a gluten-free diet.
- Family
- Tight-junction research peptide
- Research target
- Intestinal barrier regulation
- Molecular form
- Octapeptide
What to know about the research
The phase 2 study had mixed, dose-dependent findings. It does not establish that gluten avoidance can be stopped; subsequent trial history also matters.
Check the exact compound
Confirm the peptide and acetate form and distinguish a studied formulation from a generic research preparation.
What supports this entry?
The reference list is available. A statement-by-statement source check has not been completed for this entry.
These are selected references, not a complete review of the literature. Source checks were assisted by AI and have not received independent expert review.
Research stage, study quality and regulatory status answer different questions. A study card does not establish treatment benefit or approval.
No study details have been extracted for this exact entry yet. This does not mean that no studies exist. Open the references and check the exact material.
How we prepare and correct these entries